Protein Kinase CK2 Protects Multiple Myeloma Cells from ER Stress–Induced Apoptosis and from the Cytotoxic Effect of HSP90 Inhibition through Regulation of the Unfolded Protein Response

Sabrina Manni(University of Padua), Francesco Piazza(University of Padua)

Clinical Cancer Research

February 20, 2012

10.1158/1078-0432.ccr-11-1789

Cited by 83

Related Papers

Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells

|PLoS ONE|2013|92

Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death

|BMC Cancer|2010|44

Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways

|Oncotarget|2017|37

Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma

|Frontiers in Oncology|2021|5